Barely Significant
← all excerpts

Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.

Cardiovasc Res · 2017 · PMC5412020 · PMID 28453725

1
hedged sentence
closest p
boldest claim

The sentences

a decreasing trendno p-value reported
Methods and results In healthy peripartum women, serum Relaxin-2 levels (measured by ELISA in the second half of pregnancy) were elevated showing a decreasing trend in the first postpartum week and returned to non-pregnant levels thereafter.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.